BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martínez-Puchol S, Gomes C, Pons MJ, Ruiz-Roldán L, Torrents de la Peña A, Ochoa TJ, Ruiz J. Development and analysis of furazolidone-resistant Escherichia coli mutants. APMIS 2015;123:676-81. [PMID: 26011027 DOI: 10.1111/apm.12401] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 García V, Montero I, Bances M, Rodicio R, Rodicio MR. Incidence and Genetic Bases of Nitrofurantoin Resistance in Clinical Isolates of Two Successful Multidrug-Resistant Clones of Salmonella enterica Serovar Typhimurium: Pandemic "DT 104" and pUO-StVR2. Microb Drug Resist 2017;23:405-12. [PMID: 27809653 DOI: 10.1089/mdr.2016.0227] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
2 Ye JZ, Su YB, Lin XM, Lai SS, Li WX, Ali F, Zheng J, Peng B. Alanine Enhances Aminoglycosides-Induced ROS Production as Revealed by Proteomic Analysis. Front Microbiol 2018;9:29. [PMID: 29441044 DOI: 10.3389/fmicb.2018.00029] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
3 Le VVH, Olivera C, Spagnuolo J, Davies IG, Rakonjac J. In vitro synergy between sodium deoxycholate and furazolidone against enterobacteria. BMC Microbiol 2020;20:5. [PMID: 31906851 DOI: 10.1186/s12866-019-1668-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Le VVH, Davies IG, Moon CD, Wheeler D, Biggs PJ, Rakonjac J. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli. Antimicrob Agents Chemother 2019;63:e00868-19. [PMID: 31481448 DOI: 10.1128/AAC.00868-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Ruiz J, Flores-Paredes W, Luque N, Albornoz R, Rojas N, Espinoza M, Pons MJ. Retrospective analysis of the emergence of antibiotic-resistant Salmonella enterica infections in a level IV hospital from Lima, Peru. Trop Doct 2021;:494755211060990. [PMID: 34918604 DOI: 10.1177/00494755211060990] [Reference Citation Analysis]
6 Medina AM, Rivera FP, Pons MJ, Riveros M, Gomes C, Bernal M, Meza R, Maves RC, Huicho L, Chea-Woo E, Lanata CF, Gil AI, Ochoa TJ, Ruiz J. Comparative analysis of antimicrobial resistance in enterotoxigenic Escherichia coli isolates from two paediatric cohort studies in Lima, Peru. Trans R Soc Trop Med Hyg 2015;109:493-502. [PMID: 26175267 DOI: 10.1093/trstmh/trv054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
7 Kannigadu C, N'Da DD. Recent Advances in the Synthesis and Development of Nitroaromatics as Anti-Infective Drugs. Curr Pharm Des 2020;26:4658-74. [PMID: 32228417 DOI: 10.2174/1381612826666200331091853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]